Your session is about to expire
← Back to Search
Hypofractionated Radiation Therapy for Prostate Cancer
Study Summary
This trial will test a new, more effective radiation therapy regimen for prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My prostate cancer is in an early stage and my PSA level is below 10 ng/ml.My prostate cancer has a low Gleason score.I have chosen external beam radiation to treat my prostate cancer.My prostate cancer has a Gleason score of 7 or higher.I have had chemotherapy or radiation therapy to the pelvis before.I have a history of inflammatory bowel disease.My prostate cancer is confirmed and has not spread outside the prostate.My cancer has spread to nearby lymph nodes.I have been cancer-free for 5 years, except for minor skin or superficial bladder cancers.My cancer is at an advanced local stage.My cancer has spread to distant parts of my body.I have had major surgery for prostate cancer.
- Group 1: Hypofractionated radiation therapy in prostate adenocarcinoma
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people currently being recruited for this trial?
"According to the latest information available on clinicaltrials.gov, this particular trial is not actively recruiting patients at this time. This study was originally posted on December 22nd, 2008 and was last updated on March 18th, 2022. Even though this specific trial is no longer looking for participants, there are 2095 other studies that are currently seeking candidates."
Has the FDA given its blessing to hypofractionation?
"Given that this is a Phase 2 trial, and thus there is only evidence of safety and no efficacy, our team at Power has given hypofractionation a score of 2."
Would this research be beneficial for octogenarians?
"Eligible patients for this study must be aged 18 or over, but not yet 100 years old."
Are there any restrictions on who is eligible to participate in this research?
"Researchers conducting this study are looking for 188 men, aged 18 to 100, who have been diagnosed with prostate cancer and meet the following additional requirements: The patient has decided to undergo external beam radiation as treatment choice for his prostate cancer, Histologically confirmed, locally confined adenocarcinoma of the prostate, Clinical stages T1a to T2b PSA of less than 10 ng per ml, Gleason score of less than 3+4=7, Signed study-specific consent form prior to registration."
Share this study with friends
Copy Link
Messenger